إعلان
إعلان

GKOS

GKOS logo

Glaukos Corporation

112.26
USD
برعاية
-0.25
-0.22%
٠٦ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

112.32

+0.06
+0.05%

تقارير أرباح GKOS

النسبة الإيجابية المفاجئة

GKOS تفوق 28 من 40 آخر التقديرات.

70%

التقرير التالي

بيانات التقرير القادم
١٨ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$132.09M
/
-$0.21
التغير الضمني من Q3 25 (Revenue/ EPS)
-1.09%
/
+31.25%
التغير الضمني من Q4 24 (Revenue/ EPS)
+25.20%
/
-47.50%

Glaukos Corporation earnings per share and revenue

On ٢٩ أكتوبر ٢٠٢٥, GKOS reported earnings of -0.16 USD per share (EPS) for Q3 25, beating the estimate of -0.26 USD, resulting in a 39.14% surprise. Revenue reached 133.54 مليون, compared to an expected 124.99 مليون, with a 6.84% difference. The market reacted with a +13.89% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 المحللين forecast an EPS of -0.21 USD, with revenue projected to reach 132.09 مليون USD, implying an زيادة of 31.25% EPS, and نقصان of -1.09% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
٠٦ يناير ٢٠٢٦ إلى ربع سنوي2 26
تقدير
-$0.10
الفعلي
$0.00
مفاجئة
+100.00%
الأسئلة الشائعة
For Q3 2025, Glaukos Corporation reported EPS of -$0.16, beating estimates by 39.14%, and revenue of $133.54M, 6.84% above expectations.
The stock price moved up 13.89%, changed from $77.09 before the earnings release to $87.80 the day after.
The next earning report is scheduled for ١٨ فبراير ٢٠٢٦.
Based on 18 المحللين, Glaukos Corporation is expected to report EPS of -$0.21 and revenue of $132.09M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان